vTv Therapeutics Inc (VTVT)
23.94
-5.18
(-17.79%)
USD |
NASDAQ |
May 02, 16:00
23.94
0.00 (0.00%)
After-Hours: 17:00
vTv Therapeutics Net Income (Quarterly): -3.478M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.478M |
| September 30, 2023 | -6.654M |
| June 30, 2023 | -5.619M |
| March 31, 2023 | -4.499M |
| December 31, 2022 | -4.745M |
| September 30, 2022 | -4.261M |
| June 30, 2022 | -3.151M |
| March 31, 2022 | -7.007M |
| December 31, 2021 | -7.051M |
| September 30, 2021 | -1.087M |
| June 30, 2021 | -0.608M |
| March 31, 2021 | -4.241M |
| December 31, 2020 | 1.126M |
| September 30, 2020 | -1.533M |
| June 30, 2020 | -3.368M |
| March 31, 2020 | -4.724M |
| December 31, 2019 | -4.399M |
| September 30, 2019 | -3.608M |
| June 30, 2019 | -2.882M |
| March 31, 2019 | -2.155M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.091M |
| September 30, 2018 | -0.796M |
| June 30, 2018 | -3.072M |
| March 31, 2018 | -2.952M |
| December 31, 2017 | -4.311M |
| September 30, 2017 | -3.65M |
| June 30, 2017 | -3.963M |
| March 31, 2017 | -4.22M |
| December 31, 2016 | -4.05M |
| September 30, 2016 | -3.993M |
| June 30, 2016 | -4.457M |
| March 31, 2016 | -3.852M |
| December 31, 2015 | -3.169M |
| September 30, 2015 | -4.103M |
| June 30, 2015 | -10.41M |
| March 31, 2015 | -9.813M |
| December 31, 2014 | -7.715M |
| September 30, 2014 | -5.87M |
| June 30, 2014 | -7.404M |
| March 31, 2014 | -15.11M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.051M
Minimum
Dec 2021
1.126M
Maximum
Dec 2020
-3.778M
Average
-4.241M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
| Altimmune Inc | -31.64M |
| Palatin Technologies Inc | -7.844M |
| Oragenics Inc | -12.75M |
| Viking Therapeutics Inc | -27.36M |
| G1 Therapeutics Inc | -10.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.707M |
| EPS Diluted (Quarterly) | -1.31 |
| Enterprise Value | 67.72M |
| Earnings Yield | -40.56% |
| Normalized Earnings Yield | -41.77 |